Feasibility and safety of high-dose adenosine perfusion cardiovascular magnetic resonance

Journal of Cardiovascular Magnetic Resonance

Volumn 12, Issue 1, 2010, Pages

  Karamitsos, Theodoros D ^a   Ntusi, Ntobeko Ab ^a   Francis, Jane M ^a   Holloway, Cameron J ^a   Myerson, Saul G ^a   Neubauer, Stefan ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; GADODIAMIDE; GADOTERATE MEGLUMINE; DIAGNOSTIC AGENT; VASODILATOR AGENT;

3RD DEGREEE; ADOLESCENT; ADULT; AGED; ANGINA PECTORIS; ARTICLE; ATRIOVENTRICULAR BLOCK; CARDIOVASCULAR MAGNETIC RESONANCE; CHEST TIGHTNESS; CONTINUOUS INFUSION; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; DIZZINESS; DRUG DOSE INCREASE; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERANCE; DYSPNEA; ELECTROCARDIOGRAM; FEASIBILITY STUDY; FEMALE; FLUSHING; HEADACHE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HUMAN; INFUSION RATE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; SECOND DEGREE ATRIOVENTRICULAR BLOCK; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; THORAX PAIN; TREATMENT CONTRAINDICATION; AGE; BLOOD PRESSURE; CHEMICALLY INDUCED DISORDER; CHI SQUARE DISTRIBUTION; CORONARY ARTERY BLOOD FLOW; DOSE RESPONSE; DRUG EFFECT; ELECTROCARDIOGRAPHY; HEART STROKE VOLUME; HEMODYNAMICS; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PREDICTIVE VALUE; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; UNITED KINGDOM; VASODILATATION;

ADENOSINE; ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ATRIOVENTRICULAR BLOCK; BLOOD PRESSURE; CHEST PAIN; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; ENGLAND; FEASIBILITY STUDIES; FEMALE; HEART RATE; HEMODYNAMICS; HUMANS; INFUSIONS, INTRAVENOUS; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; STROKE VOLUME; VASODILATION; VASODILATOR AGENTS; YOUNG ADULT;

EID: 79952793558     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-12-66     Document Type: Article

References (25)

1. Myocardial first-pass perfusion cardiovascular magnetic resonance: history, theory, and current state of the art. Gerber BL, Raman SV, Nayak K, Epstein FH, Ferreira P, Axel L, Kraitchman DL, J Cardiovasc Magn Reson 2008 10 18 10.1186/1532-429X-10-18 18442372
2. Stress Perfusion Imaging Using Cardiovascular Magnetic Resonance: A Review. Christiansen JP, Karamitsos TD, Myerson SG, Francis JM, Neubauer S, Heart Lung Circ 2010
3. Tolerance and safety of adenosine stress perfusion cardiovascular magnetic resonance imaging in patients with severe coronary artery disease. Karamitsos TD, Arnold JR, Pegg TJ, Cheng AS, van Gaal WJ, Francis JM, Banning AP, Neubauer S, Selvanayagam JB, Int J Cardiovasc Imaging 2009 25 277 283 10.1007/s10554-008-9392-3 19037746
4. Effects of adenosine on human coronary arterial circulation. Wilson RF, Wyche K, Christensen BV, Zimmer S, Laxson DD, Circulation 1990 82 1595 1606 2225364 (Pubitemid 20367962)
5. Clinical determinants of hemodynamic and symptomatic responses in 2,000 patients during adenosine scintigraphy. Johnston DL, Hodge DO, Hopfenspirger MR, Gibbons RJ, Mayo Clin Proc 1998 73 314 320 10.4065/73.4.314 9559034 (Pubitemid 28169682)
6. Prognostic impact of hemodynamic response to adenosine in patients older than age 55 years undergoing vasodilator stress myocardial perfusion study. Abidov A, Hachamovitch R, Hayes SW, Ng CK, Cohen I, Friedman JD, Germano G, Berman DS, Circulation 2003 107 2894 2899 10.1161/01.CIR.0000072770.27332.75 12796141 (Pubitemid 36736629)
7. Operator induced variability in left ventricular measurements with cardiovascular magnetic resonance is improved after training. Karamitsos TD, Hudsmith LE, Selvanayagam JB, Neubauer S, Francis JM, J Cardiovasc Magn Reson 2007 9 777 783 10.1080/10976640701545073 17891615 (Pubitemid 47463903)
8. Safety profile of adenosine stress perfusion imaging: results from the Adenoscan Multicenter Trial Registry. Cerqueira MD, Verani MS, Schwaiger M, Heo J, Iskandrian AS, J Am Coll Cardiol 1994 23 384 389 10.1016/0735-1097(94)90424-3 8294691 (Pubitemid 24049369)
9. Cardiovascular and respiratory effects of adenosine in conscious man. Evidence for chemoreceptor activation. Biaggioni I, Olafsson B, Robertson RM, Hollister AS, Robertson D, Circ Res 1987 61 779 786 3677336 (Pubitemid 18004572)
10. Coronary vasoactivity of adenosine in the conscious dog. Olsson RA, Khouri EM, Bedynek JL Jr, McLean J, Circ Res 1979 45 468 478 476869 (Pubitemid 10245188)
11. Influence of age and hemodynamics on myocardial blood flow and flow reserve. Czernin J, Muller P, Chan S, Brunken RC, Porenta G, Krivokapich J, Chen K, Chan A, Phelps ME, Schelbert HR, Circulation 1993 88 62 69 8319357 (Pubitemid 23195433)
12. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Hasking GJ, Esler MD, Jennings GL, Burton D, Johns JA, Korner PI, Circulation 1986 73 615 621 3948363 (Pubitemid 16081418)
13. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. Triposkiadis F, Karayannis G, Giamouzis G, Skoularigis J, Louridas G, Butler J, J Am Coll Cardiol 2009 54 1747 1762 10.1016/j.jacc.2009.05.015 19874988
14. The A2A adenosine receptor mediates coronary vasodilation. Belardinelli L, Shryock JC, Snowdy S, Zhang Y, Monopoli A, Lozza G, Ongini E, Olsson RA, Dennis DM, J Pharmacol Exp Ther 1998 284 1066 1073 9495868 (Pubitemid 28130836)
15. Greater adenosine A(2A) receptor densities in cardiac and skeletal muscle in endurance-trained men: a [11C]TMSX PET study. Mizuno M, Kimura Y, Tokizawa K, Ishii K, Oda K, Sasaki T, Nakamura Y, Muraoka I, Ishiwata K, Nucl Med Biol 2005 32 831 836 10.1016/j.nucmedbio.2005.07.003 16253807 (Pubitemid 41505316)
16. Adenosine receptors and the heart: role in regulation of coronary blood flow and cardiac electrophysiology. Mustafa SJ, Morrison RR, Teng B, Pelleg A, Handb Exp Pharmacol 2009 161 188 full-text 19639282
17. Targeted deletion of adenosine A(3) receptors augments adenosine-induced coronary flow in isolated mouse heart. Talukder MA, Morrison RR, Jacobson MA, Jacobson KA, Ledent C, Mustafa SJ, Am J Physiol Heart Circ Physiol 2002 282 2183 2189 12003827
18. Adequate intracoronary adenosine doses to achieve maximum hyperaemia in coronary functional studies by pressure derived fractional flow reserve: a dose response study. Lopez-Palop R, Saura D, Pinar E, Lozano I, Perez-Lorente F, Pico F, Valdez M, Heart 2004 90 95 96 10.1136/heart.90.1.95 14676256 (Pubitemid 38064557)
19. Adenosine-induced maximal coronary hyperemia for myocardial fractional flow reserve measurements: comparison of administration by femoral venous versus antecubital venous access. Lindstaedt M, Bojara W, Holland-Letz T, Yazar A, Fadgyas T, Muller L, Mugge A, Germing A, Clin Res Cardiol 2009 98 717 723 10.1007/s00392-009-0056-7 19685258
20. Intravenous adenosine: continuous infusion and low dose bolus administration for determination of coronary vasodilator reserve in patients with and without coronary artery disease. Kern MJ, Deligonul U, Tatineni S, Serota H, Aguirre F, Hilton TC, J Am Coll Cardiol 1991 18 718 729 10.1016/0735-1097(91)90795-B 1869735
21. High dose adenosine stress echocardiography for noninvasive detection of coronary artery disease. Djordjevic-Dikic AD, Ostojic MC, Beleslin BD, Stepanovic J, Petrasinovic Z, Babic R, Stojkovic SM, Stankovic G, Nedeljkovic M, Nedeljkovic I, Kanjuh V, J Am Coll Cardiol 1996 28 1689 1695 10.1016/S0735-1097(96)00374-9 8962553 (Pubitemid 26426221)
22. High-dose adenosine overcomes the attenuation of myocardial perfusion reserve caused by caffeine. Reyes E, Loong CY, Harbinson M, Donovan J, Anagnostopoulos C, Underwood SR, J Am Coll Cardiol 2008 52 2008 2016 10.1016/j.jacc.2008.08.052 19055993
23. Effect of caffeine on ischemia detection by adenosine single-photon emission computed tomography perfusion imaging. Zoghbi GJ, Htay T, Aqel R, Blackmon L, Heo J, Iskandrian AE, J Am Coll Cardiol 2006 47 2296 2302 10.1016/j.jacc.2005.11.088 16750699 (Pubitemid 43795068)
24. Effect of caffeine administered intravenously on intracoronary- administered adenosine-induced coronary hemodynamics in patients with coronary artery disease. Aqel RA, Zoghbi GJ, Trimm JR, Baldwin SA, Iskandrian AE, Am J Cardiol 2004 93 343 346 10.1016/j.amjcard.2003.10.017 14759387 (Pubitemid 38167434)
25. Quantitative relation between hemodynamic changes during intravenous adenosine infusion and the magnitude of coronary hyperemia: implications for myocardial perfusion imaging. Mishra RK, Dorbala S, Logsetty G, Hassan A, Heinonen T, Schelbert HR, Di Carli MF, J Am Coll Cardiol 2005 45 553 558 10.1016/j.jacc.2004.10.064 15708703 (Pubitemid 40222250)